In parallel, RMC tumor cells upregulated expression of IFNGR1 (Fig. 2f), which normally engages IFNγ to activate proliferation of myeloid lineage immune cells via the MAPK signaling pathway as part of the innate immune response18,19. Here, IFNGR1 is linked to neoplasm.